Prognostic Significance of Plasmablastic Plasma Cells in the Era of Novel Agents in Multiple Myeloma

被引：0
|
作者：
Machet, Antoine
Guidez, Stephanie
Fouquet, Guillemette
Systchenko, Thomas
Desmier, Deborah
Moya, Niels
Gruchet, Cecile
Levy, Anthony
Sabirou, Florence
Bobin, Arthur
Richez, Valentine
Dieval, Celine
Motard, Carine
Borde, Florence
Durand, Geraldine
Azais, Isabelle
Javaugue, Vincent
Tomowiak, Cecile
Bouyer, Sabrina
Ghoual, Ouda
Dindinaud, Elodie
Bridoux, Frank
Sonneveld, Pieter
Loiseau, Herve Avet
Leleu, Xavier
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1877
引用
收藏
页数：2
相关论文
共 50 条
  • [31] BONE MARROW PLASMA CELLS ASSESSMENT DOES NOT IMPACT ON PERIPHERAL BLOOD STEM CELLS MOBILIZATION IN MULTIPLE MYELOMA PATIENTS IN THE NOVEL AGENTS ERA
    Donnini, I.
    Antonioli, E.
    Staderini, M.
    Nozzoli, C.
    Bacchiarri, F.
    Urbani, S.
    Saccardi, R.
    Guidi, S.
    Bosi, A.
    HAEMATOLOGICA, 2015, 100 : 158 - 158
  • [32] PROGNOSTIC SIGNIFICANCE OF MORPHOLOGICAL EVALUATION OF TUMOR CELLS IN MULTIPLE MYELOMA
    Alsahmani, M.
    Trnavska, I.
    Antosova, M.
    Antosova, L.
    Liasova, J.
    Adam, Z.
    Pour, L.
    Krejci, M.
    Zahradova, L.
    Bulikova, A.
    Penka, M.
    Hajek, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 570 - 571
  • [33] The clinical significance of CD49e and CD56 for multiple myeloma in the novel agents era
    Miyuki Okura
    Naoko Ida
    Takahiro Yamauchi
    Medical Oncology, 2020, 37
  • [34] The clinical significance of CD49e and CD56 for multiple myeloma in the novel agents era
    Okura, Miyuki
    Ida, Naoko
    Yamauchi, Takahiro
    MEDICAL ONCOLOGY, 2020, 37 (11)
  • [35] Improved survival of older patients with multiple myeloma in the era of novel agents
    Mey, Ulrich J. M.
    Leitner, Christoph
    Driessen, Christoph
    Cathomas, Richard
    Klingbiel, Dirk
    Hitz, Felicitas
    HEMATOLOGICAL ONCOLOGY, 2016, 34 (04) : 217 - 223
  • [36] The initial management of multiple myeloma in the era of novel agents: 2021 and beyond
    Nadeem, Omar
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (02) : 213 - 215
  • [37] Front line treatment of elderly multiple myeloma in the era of novel agents
    Venon, Marie-Dominique
    Roccaro, Aldo M.
    Gay, Julie
    Moreau, Anne-Sophie
    Dulery, Remy
    Facon, Thierry
    Ghobrial, Irene M.
    Leleu, Xavier
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 99 - 109
  • [38] Treatment of Multiple Myeloma in Akita: Features and Outcomes in the Era of Novel Agents
    Shida, Seiji
    Takahashi, Naoto
    Niioka, Takenori
    Kitabayashi, Atsushi
    Kawabata, Yoshinari
    Kume, Masaaki
    Saitoh, Hirobumi
    Hatano, Yoshiaki
    Ichikawa, Yoshikazu
    Kuroki, Jun
    Motegi, Mutsuhito
    Kobayashi, Takahiro
    Kameoka, Yoshihiro
    Tagawa, Hiroyuki
    Fujishima, Naohito
    Yoshioka, Tomoko
    Hirokawa, Makoto
    Miura, Masatomo
    Sawada, Kenichi
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2014, 54 (01) : 89 - 93
  • [39] Multiple Myeloma in the Era of Novel Agents: A Single-Center Study
    Lopes, Danielle Ovigli
    Arcuri, Leonardo
    Marques, Carolina
    Kerbauy, Mariana
    Moura, Fernando
    Helman, Ricardo
    Silva, Cinthya
    RIbeiro, Andreza
    Hamerschlak, Nelson
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S187 - S188
  • [40] Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Agents
    Shimazaki, Chihiro
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01): : 14 - 15
12345